Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinsuke Yasuda

Showing results (1-10 of 153) with videos related to

Pageof 16
Sort By:
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|February 1, 2005
[Pathogenic roles of anti-beta2-GPI antibody in patients with antiphospholipid syndrome]Shinsuke Yasuda
Modern Rheumatology|June 28, 2018
Emerging targets for the treatment of lupus erythematosus: There is no royal road to treating lupusShinsuke Yasuda
Clinical Calcium|May 8, 2018
[Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Best practice in the use of T cell co-stimulatory inhibitor for patients with rheumatoid arthritis.]Shinsuke Yasuda
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|November 1, 2006
[New insights into the pathogenicity of antiphospholipid antibodies]Shinsuke Yasuda, Takao Koike
Journal of Cachexia, Sarcopenia and Muscle|July 1, 2022
Amelioration of inflammatory myopathies by glucagon-like peptide-1 receptor agonist via suppressing muscle fibre necroptosisMari Kamiya, Fumitaka Mizoguchi, Shinsuke Yasuda
Rheumatology International|April 7, 2018
The role of genetics and epigenetics in rheumatic diseases: are they really a target to be aimed at?Masaru Kato, Shinsuke Yasuda, Tatsuya Atsumi
Current Rheumatology Reports|July 26, 2017
How to Identify High-Risk APS Patients: Clinical Utility and Predictive Values of Validated ScoresKenji Oku, Olga Amengual, Shinsuke Yasuda, et al.
Immunobiology|December 6, 2005
Pathogenesis of antiphospholipid antibodies: impairment of fibrinolysis and monocyte activation via the p38 mitogen-activated protein kinase pathwayShinsuke Yasuda, Miyuki Bohgaki, Tatsuya Atsumi, et al.
Thrombosis Research|October 28, 2004
Antiprothrombin antibodies--are they worth assaying?Tatsuya Atsumi, Olga Amengual, Shinsuke Yasuda, et al.
Modern Rheumatology Case Reports|May 28, 2025
Successful treatment with tocilizumab in a case of familial Mediterranean fever with Takayasu arteritisSaeka Kondo, Natsuka Umezawa, Yasuhiro Tagawa, et al.
Pageof 16

Showing results (1-10 of 153) with videos related to

Sort By:
Pageof 16
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|February 1, 2005
[Pathogenic roles of anti-beta2-GPI antibody in patients with antiphospholipid syndrome]Shinsuke Yasuda
Modern Rheumatology|June 28, 2018
Emerging targets for the treatment of lupus erythematosus: There is no royal road to treating lupusShinsuke Yasuda
Clinical Calcium|May 8, 2018
[Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Best practice in the use of T cell co-stimulatory inhibitor for patients with rheumatoid arthritis.]Shinsuke Yasuda
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|November 1, 2006
[New insights into the pathogenicity of antiphospholipid antibodies]Shinsuke Yasuda, Takao Koike
Journal of Cachexia, Sarcopenia and Muscle|July 1, 2022
Amelioration of inflammatory myopathies by glucagon-like peptide-1 receptor agonist via suppressing muscle fibre necroptosisMari Kamiya, Fumitaka Mizoguchi, Shinsuke Yasuda
Rheumatology International|April 7, 2018
The role of genetics and epigenetics in rheumatic diseases: are they really a target to be aimed at?Masaru Kato, Shinsuke Yasuda, Tatsuya Atsumi
Current Rheumatology Reports|July 26, 2017
How to Identify High-Risk APS Patients: Clinical Utility and Predictive Values of Validated ScoresKenji Oku, Olga Amengual, Shinsuke Yasuda, et al.
Immunobiology|December 6, 2005
Pathogenesis of antiphospholipid antibodies: impairment of fibrinolysis and monocyte activation via the p38 mitogen-activated protein kinase pathwayShinsuke Yasuda, Miyuki Bohgaki, Tatsuya Atsumi, et al.
Thrombosis Research|October 28, 2004
Antiprothrombin antibodies--are they worth assaying?Tatsuya Atsumi, Olga Amengual, Shinsuke Yasuda, et al.
Modern Rheumatology Case Reports|May 28, 2025
Successful treatment with tocilizumab in a case of familial Mediterranean fever with Takayasu arteritisSaeka Kondo, Natsuka Umezawa, Yasuhiro Tagawa, et al.
Pageof 16